Ketamine for OCD
When intrusive thoughts and compulsions keep running the day despite SSRIs and therapy, emerging research on the glutamate system suggests another possible lever — offered here with honest expectations.
You Know the Thoughts Aren't Rational.
That's Never Been the Problem.
OCD is one of the most misunderstood conditions in mental health — reduced in popular culture to tidiness, when the reality is intrusive thoughts that horrify you precisely because they're so foreign to who you are, and rituals that consume hours as the price of momentary relief. If high-dose SSRIs and exposure therapy (ERP) haven't been enough, you've already done the hard, correct things. Some patients in that position look to emerging options — and deserve straight answers about them.
The Glutamate Hypothesis of OCD
Research has increasingly implicated glutamate signaling in the cortico-striatal circuits that drive obsessions and compulsions — one reason glutamate-modulating agents have become an active frontier in OCD research. Ketamine, as an NMDA-receptor modulator that promotes rapid neuroplasticity, has been studied for its ability to interrupt the obsessive loop, with some patients in early trials reporting rapid reductions in obsessional intensity.
Honest framing — please read: Of the conditions we treat, OCD has one of the younger evidence bases. Early controlled and open-label studies have reported rapid anti-obsessional effects in some patients, with variable durability; other studies have been mixed, and larger trials are ongoing. Ketamine for OCD is off-label, is not a first-line treatment, and works best considered alongside — never instead of — ERP therapy and medication management. If we don't think the evidence supports trying it in your case, we will tell you exactly that.
How We Approach OCD at Desert Sands
Your evaluation covers your OCD history and symptom profile, prior medication trials and therapy (especially ERP), co-occurring depression or anxiety — common alongside OCD and an area where ketamine's evidence is stronger — and your medical background. Treatment protocols are physician-directed and supported by experienced clinical staff under the medical oversight of board-certified anesthesiologist Dr. Eric Evans, whose more than 30 years of clinical experience help guide the highest standards of patient safety, comfort, and care. If you're working with an OCD therapist, we'll coordinate — some patients find the window after infusions a productive time for ERP work.
Patient Selection
- Have OCD that persists despite adequate trials of SSRIs and ERP therapy
- Have significant co-occurring depression or anxiety alongside OCD
- Are engaged in, or willing to engage in, ongoing OCD-focused care
- Want an honest assessment of an emerging option, not a sales pitch
- OCD that hasn't yet had an adequate trial of first-line treatment — ERP and medication come first
- A history of psychosis or schizophrenia
- Uncontrolled blood pressure or unstable cardiovascular disease
- Active substance-use concerns that haven't been evaluated
Outcomes, Honestly Stated
Patients who respond describe the obsessional volume dropping — the thoughts arriving with less force, the compulsions easier to resist, especially in the days following infusion. Durability is the open question in the research and in practice: some patients sustain benefit with maintenance and concurrent ERP; others find the effect short-lived. We measure symptoms across your course and will tell you candidly whether the response justifies continuing.
Risks and side effects
During and shortly after infusion, patients may experience dissociation, elevated blood pressure or heart rate, nausea, dizziness, or drowsiness — typically temporary, with most resolving within about two hours. For some OCD patients, the dissociative experience initially feeds anxiety about losing control; we discuss this frankly beforehand, start conservatively, and adjust in real time. Every patient is screened and continuously monitored, and you'll need a ride home after each session.
What the Research Shows
Proof-of-concept randomized work and subsequent studies have reported rapid reductions in obsessions in a subset of patients following ketamine infusion, supporting the glutamate hypothesis of OCD, while reviews consistently note mixed durability findings and call for larger trials. We present it to patients the way the literature presents it: promising, early, and worth an honest individualized conversation.
OCD Treatment FAQ
Should I do this instead of ERP therapy?
No — and we'll say that plainly in your consultation too. ERP remains the best-supported treatment for OCD. Ketamine is considered as an addition for refractory cases, and some patients use the post-infusion window to engage ERP more effectively.
What if my OCD themes involve health or contamination — will the clinic be hard for me?
Tell us. Private rooms, a consistent small team, and walking you through every step in advance are already how we operate — and we're glad to make specific accommodations that make treatment tolerable rather than a trigger.
You've Fought This Loop
Longer Than Anyone Knows
Your free consultation is an honest conversation about your OCD history and whether ketamine is a reasonable addition to your care — including if the answer is "not yet."
Request Your Free ConsultationCall (435) 522-5190This page is for educational purposes and is not medical advice. Ketamine is FDA-approved as an anesthetic; its use for OCD is off-label with an emerging evidence base. Individual results vary and are not guaranteed. Reading this page or submitting a form does not create a provider-patient relationship. If you are experiencing a mental-health emergency, call 911 or call/text 988.